| Literature DB >> 26960075 |
Chi Yuet X'avia Chan1, Marina A Gritsenko1, Richard D Smith1, Wei-Jun Qian1.
Abstract
Protein phosphorylation is a fundamental regulatory mechanism in many cellular processes and aberrant perturbation of phosphorylation has been implicated in various human diseases. Kinases and their cognate inhibitors have been considered as hotspots for drug development. Therefore, the emerging tools, which enable a system-wide quantitative profiling of phosphoproteome, would offer a powerful impetus in unveiling novel signaling pathways, drug targets and/or biomarkers for diseases of interest. This review highlights recent advances in phosphoproteomics, the current state of the art of the technologies and the challenges and future perspectives of this research area. Finally, some exemplary applications of phosphoproteomics in diabetes research are underscored.Entities:
Keywords: LC-MS/MS; Phosphoproteomics; diabetes; phosphopeptide enrichment; phosphorylation; quantification; targeted proteomics
Mesh:
Substances:
Year: 2016 PMID: 26960075 PMCID: PMC4939282 DOI: 10.1586/14789450.2016.1164604
Source DB: PubMed Journal: Expert Rev Proteomics ISSN: 1478-9450 Impact factor: 3.940